Vitamin D for Heart Failure
C Some Evidence Limited evidence from small studies, but some positive signals exist.D-CURE trial showed no benefit in heart failure patients. EVITA found high-dose D3 did not improve outcomes. Some observational data supports benefit with deficiency correction.
The Bottom Line
D-CURE trial showed no benefit in heart failure patients. EVITA found high-dose D3 did not improve outcomes. Some observational data supports benefit with deficiency correction.
Key Study Findings
Population: Chronic heart failure patients
Key Statistics
6
Studies
3000
Participants
Mixed
Grade
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Commonly Used Dosages
- general:
- 600-800 IU/day
- deficiencycorrection:
- 4,000-5,000 IU/day (under medical supervision)
- cardiovascularsupport:
- 1,000-2,000 IU/day
Upper limit: 4,000 IU/day (100 mcg)
Dosages Studied in Research
| Dosage | Duration | Effect | N |
|---|---|---|---|
| None | -- | Mixed | -- |
Best taken: With a meal containing fat for better absorption
Safety & Side Effects
Reported Side Effects
- ⚠ Hypercalcemia at very high doses (fatigue, nausea, kidney stones)
- ⚠ Constipation
- ⚠ Generally very safe at recommended doses
Known Interactions
- ● Thiazide diuretics (may increase hypercalcemia risk)
- ● Statins (theoretical interaction via CYP enzymes)
- ● Corticosteroids (may reduce vitamin D absorption)
- ● Weight loss medications (may reduce absorption of fat-soluble vitamins)
Tolerable upper intake: 4,000 IU/day (100 mcg)
Always consult your healthcare provider before starting any supplement.
Frequently Asked Questions
Does Vitamin D help with Heart Failure?
How much Vitamin D should I take for Heart Failure?
Are there side effects of Vitamin D?
How strong is the evidence for Vitamin D and Heart Failure?
Related Evidence
Other ingredients for Heart Failure
Vitamin D for other conditions
References
- [1] George Georgiopoulos et al.. Curr Pharm Des. 2017. Vitamins in Heart Failure: Friend or Enemy? doi:10.2174/1381612823666170321094711 PubMed
- [2] Barbara J Messinger-Rapport et al.. J Am Med Dir Assoc. 2007. Intensive session: New approaches to medical issues in long-term care. doi:10.1016/j.jamda.2007.07.002 PubMed
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.